Stay updated on Vilazodone Safety in GAD: Clinical Trial
Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.

Latest updates to the Vilazodone Safety in GAD: Clinical Trial page
- Check3 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the study record content, effectively making the NCT01844115 page inaccessible to users.SummaryDifference17%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision metadata updated from v3.6.5 to v3.6.6, indicating a minor maintenance update to the page. It does not reflect changes to the study details or outcomes.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page shows a new Revision: v3.6.5, replacing the prior v3.6.4, indicating a site version update rather than a change to study information.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small update to the page's version information.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page's revision line now shows version 3.6.3, replacing 3.6.2. This indicates a software release update for the page.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page now shows revision v3.6.2 in place of the previous v3.6.0, indicating a backend/UI update. This change does not modify the study information presented on the page.SummaryDifference0.0%

Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.